AndhraNews.net
Home » Features » Hospitals » Massachusetts General Hospital

Massachusetts General Hospital


Research findings / studies at Massachusetts General Hospital

Massachusetts General Hospital in News

FluoroPharma Names Dr. Thomas Tulip, PhD Chief Executive Officer
MONTCLAIR, NJ--(Marketwired - December 29, 2015) - FluoroPharma Medical, Inc. (OTCQB: FPMI), a company specializing in the development of novel diagnostic imaging products that utilize positron emission tomography (PET) technology for the detection and assessment of disease before clinical manifestation, announced today the appointment of Dr. Thomas Tulip, PhD as Chief Executive Officer.

Study Analyzes Cost of Automated Cancer Screening Outreach Using TopCare at Massachusetts General Hospital

Kalytera Therapeutics Appoints Dr. Jeff Paley to Board of Directors
Kalytera Therapeutics, Inc., a pharmaceutical company developing a portfolio of non-psychoactive cannabinoid ("CBD") and synthetic CBD medicines intended to address the unmet needs of large patient populations, today announced it has appointed Dr. Jeff Paley, M.D., to its Board of Directors.

Aelan Cell Technologies Names Mary Lopez, Ph.D. of Nuclea Biotechnologies to Its Scientific Advisory Board
Aelan Cell Technologies announced today the appointment of Mary Lopez, Ph.D. to its Scientific Advisory Board. Dr. Lopez will serve as an advisor to Aelan's Molecular Diagnostics Division, which is developing unique diagnostic tools that are able to provide rapid and affordable assessment of organismal vitality in blood samples

Kalytera Therapeutics Appoints Dr. Jerome Zeldis to Board of Directors
Kalytera Therapeutics, Inc., a pharmaceutical company developing a portfolio of non-psychoactive cannabinoid ("CBD") and synthetic CBD medicines that address the unmet needs of large patient populations, today announced it has appointed Jerome B. Zeldis, M.D., Ph.D., to its Board of Directors.

NCCN Collaborates With Bristol-Myers Squibb to Study PD-L1 Expression and Test Interpretation in Lung Cancer
FORT WASHINGTON, PA--(Marketwired - November 30, 2015) - New molecules and pathways with pivotal functions in regulating the immune system have been discovered recently, providing new understanding of how tumor cells avoid the immune system

NCCN Foundation(R) Appoints Three New Representatives to Board of Directors
FORT WASHINGTON, PA--(Marketwired - November 20, 2015) - The NCCN Foundation® has appointed three new representatives to its Board of Directors: Heather Kopecky, PhD, MBA; Marc Samuels, JD, MPH; and Susan Stein, MPH

Ketamine Clinics of Los Angeles Completes 1,000th IV Ketamine Infusion
For an illness known as the "silent killer," depression has often loudly left its mark. First recognized centuries ago, this mental disorder has taken the lives of some of the world's most talented men and women. It's a disease that makes no distinction between rich and poor, between famous and obscure

Dr. Robert C. Young Joins NCCN Leadership Team
FORT WASHINGTON, PA--(Marketwired - November 16, 2015) - The National Comprehensive Cancer Network® (NCCN®) has appointed Robert C. Young, MD, as Interim Vice President of the NCCN Oncology Research Program (ORP).

Mesothelioma Victims Center Now Urges Individuals or Family Members of a Loved One Diagnosed With This Cancer to Call Them About the Nation's Top Regional Hospitals for the Best Possible Mesothelioma Treatment
WASHINGTON, DC--(Marketwired - November 16, 2015) - Aside from being the nation's top branded source for the best mesothelioma compensation, the Mesothelioma Victims Center is also known for honest information, such as recommendations for top regional mesothelioma treatment facilities in the nation

Dr. Christine Mummery appointed to Galapagos' Board of Directors
Mechelen, Belgium; 4 November 2015 - Galapagos NV (Euronext & NASDAQ: GLPG) announced the appointment of Dr. Christine Mummery to its Board of Directors as an independent non-executive director.

Medical Research Visionaries Convene in New York, Present Model Solutions to Life Sciences' Most Pressing Challenges
WASHINGTON, DC--(Marketwired - October 28, 2015) - More than 700 medical research innovators from 30 states and six countries will come together Nov. 1-3 in New York for the 7th annual Partnering for Cures meeting

Zeltiq Announces Third Quarter 2015 Financial Results
PLEASANTON, CA--(Marketwired - October 27, 2015) -

Cardiology Product Potential, Clinical Trial Progress and Capital Acquisition Success Drive the Company's Next Moves
MONTCLAIR, NJ--(Marketwired - October 23, 2015) - FluoroPharma Medical, Inc

Further data on selexipag (Uptravi) to be presented at CHEST 2015 Congress
Actelion Pharmaceuticals Ltd /Further data on selexipag (Uptravi) to be presented at CHEST 2015 Congress. Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

ZELTIQ Announces Location and Agenda for 2015 Investor Day
ZELTIQ® (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced the location and agenda for its 2015 investor and analyst day. The event will be held on November 17, 2015 from 9:30 a.m. ET to 12:00 p.m. ET at the Park Hyatt New York in New York City.

Anti-Androgen Therapy and Salvage RT Improves Overall Survival for a Prostate Cancer Recurrence After a Prostatectomy

Intellect Neurosciences, Inc. Issues Letter to Shareholders
NEW YORK, NY--(Marketwired - October 20, 2015) - Intellect Neurosciences, Inc. (OTCQB: ILNS) a biopharmaceutical company engaged in the discovery and development of disease-modifying therapeutic agents for the treatment and prevention of rare neurodegenerative conditions, issued the following Letter to Shareholders from Elliot Maza, CEO.

Boehringer Ingelheim Will Invest 11 Billion Euros in Research and Development in the Next Five Years to Accelerate the Discovery of Next Generation Medical Breakthroughs
Business Wire IndiaBoehringer Ingelheim is launching a new research and development (R&D) strategy and a five-year R&D investment programme. This new plan was announced at its R&D press conference in Berlin. The company pledges to invest a total of 11 billion euros in its new R&D programme over the next five years

Boehringer Ingelheim partners with leading scientific institutions in inflammatory bowel disease research
Business Wire India

Dr. Stafford Broumand Reveals Benefit of Receiving Injectables From a Plastic Surgeon
Dermal fillers and injectables can be excellent options for many people interested in facial rejuvenation, states Dr. Stafford R. Broumand, a board certified plastic surgeon in New York City

Scientific and Medical Coalition Against Cancer (SMCAC) Partners With Christopher's Haven

Boston Hospitals Cut Energy Use by 6%, Despite Continued Facility Growth
BOSTON, MA--(Marketwired - December 11, 2014) - As a result of energy conservation and efficiency, Boston hospitals have cut their energy use by 6% over the last three years, despite expanding their real estate footprint, patient care, and more extreme weather, according to a report issued today http://www.greenribboncommission.org/health-care.

HC2's Subsidiary Pansend Has Founded GemDerm Aesthetics, Inc.
HC2 Holdings, Inc. ("HC2") (OTCQB: HCHC) announced today that Pansend, LLC, its indirect wholly owned subsidiary, has founded GemDerm Aesthetics, Inc., which has licensed technology created by scientists R. Rox Anderson, M.D., Director of the Wellman Center of Photomedicine at Massachusetts General Hospital in Boston, a teaching affiliate of Harvard Medical School; Dieter Manstein, M.D., Ph.D

FluoroPharma Medical Announces Scheduled Completion of Enrollment in a Phase II Clinical Trial of CardioPET (18F FCPHA) for Assessment of Coronary Artery Disease (CAD)
MONTCLAIR, NJ--(Marketwired - December 04, 2014) - FluoroPharma Medical, Inc. (OTCQB: FPMI), a company specializing in the development of novel diagnostic imaging products that utilize positron emission tomography (PET) technology for the detection and assessment of disease before clinical manifestation, today announced that enrollment for this Phase II trial will be closing on December 15th

NCCN Launches 3D Virtual Simulator Learning Platform
FORT WASHINGTON, PA--(Marketwired - December 04, 2014) - The National Comprehensive Cancer Network® (NCCN®) has launched a 3D Virtual Metastatic Colorectal Cancer (mCRC) Simulator Learning Platform as part of the NCCN Continuing Education Program. To develop the 3D Virtual mCRC Simulator Learning platform, NCCN collaborated with Syandus, Inc

NYC Plastic Surgeon Offers Food Rehab Program to Enhance Cosmetic Surgery
"At my practice, we try to incorporate what we believe can lead to better, healthier living into every aspect of care," states Manhattan plastic surgeon Stafford R. Broumand, MD. "It's not just about plastic surgery or cosmetic enhancement -- it's about helping patients achieve and maintain complete wellness

Changing the Course of Prostate Cancer Treatment: Life Expectancy Estimation, Active Surveillance, and Drug Development
FORT WASHINGTON, PA--(Marketwired - November 21, 2014) - The National Comprehensive Cancer Network® (NCCN®) has published the 20th annual edition of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Prostate Cancer -- one of the eight original NCCN Guidelines® published in November 1996.

Improved Outcomes in Non-Small Cell Lung Cancer Due to Advancements in Screening, Diagnosis, Radiology, and Systemic Therapies
FORT WASHINGTON, PA--(Marketwired - November 19, 2014) - The National Comprehensive Cancer Network® (NCCN®) has published the 20th annual edition of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Non-Small Cell Lung Cancer (NSCLC), one of the eight original NCCN Guidelines® published in November 1996.

SomaLogic Announces Deployment of SOMAscan(TM) Proteomics Assay at University of Colorado Denver
DENVER, CO and BOULDER, CO--(Marketwired - November 18, 2014) - SomaLogic, Inc., announced today that the SOMAscan™ assay, a breakthrough proteomics platform, will be deployed at the University of Colorado Denver (UCD), Anschutz Medical Campus

Printed NCCN Guidelines for Patients(R) Now Available Through Amazon.com
FORT WASHINGTON, PA--(Marketwired - November 10, 2014) - The National Comprehensive Cancer Network® (NCCN®), with the support of the NCCN Foundation®, announces the availability of printed versions of the NCCN Guidelines for Patients® for order on Amazon

NAPA CEO Dr. John Di Capua and Other NAPA Clinicians Recognized as Health Care Heroes by Long Island Business News
MELVILLE, NY--(Marketwired - November 10, 2014) - North American Partners in Anesthesia (NAPA) announced today that three of its leading practitioners were selected by Long Island Business News as 2014 Health Care Heroes. The NAPA winners included CEO John Di Capua, MD, Neil Kirschen, MD and Winston Joseph, CRNA. Drs. Di Capua and Kirschen were selected in the Physician Hero category and Mr

Spaces Still Available for November 22 Advanced GI Therapeutics Course Offered by Presence Saint Joseph Hospital
Presence Saint Joseph Hospital in Chicago announced today that spots are still available for its upcoming educational program for physicians and nurses entitled "Advances in GI Therapeutics: Technology and Approaches in Intraluminal Therapeutics

Journal of Nuclear Cardiology Publication States Preliminary Findings of Phase II Clinical Study Suggest FluoroPharma's CardioPET Has a Promising Role for the Identification of Functionally Significant Coronary Artery Disease
MONTCLAIR, NJ--(Marketwired - November 03, 2014) - FluoroPharma Medical, Inc

NYC Plastic Surgeon 'Gives Back' by Helping Pediatric Burn Victims in Nicaragua
Outside his practice, Manhattan plastic surgeon Stafford R. Broumand, MD devotes a considerable amount of time to "giving back" to the community through various philanthropic efforts. In addition to helping those in need both locally and nationally, Dr

LumaMed Announces Breast Cancer Imaging Collaboration
Today, LumaMed and the University of Massachusetts Medical School (UMass Medical School) announce a joint clinical study using LumaMed's LumaScan imaging platform. LumaScan is designed to help surgeons visualize cancerous tissue on the margins of excised solid tumors during breast cancer surgery.

NCCN Chemotherapy Order Templates to Be Integrated Into Epic's Electronic Health Record
FORT WASHINGTON, PA--(Marketwired - October 20, 2014) - The National Comprehensive Cancer Network® (NCCN®) is working with Epic to integrate the NCCN Chemotherapy Order Templates (NCCN Templates®) into Epic's Beacon Oncology Information System as electronic chemotherapy protocols for use by health care providers.

New York Facial Plastic Surgeon Launches Responsive Website Design
To provide patients with an enhanced resource for learning, Dr. W. Matthew White, a facial plastic surgeon in New York, has upgraded his website with a new design that has responsive capabilities. The site has also been revamped with updated content on procedural pages to help patients better understand what specific treatments entail. Dr

Looking Back: 20 Years of Colorectal Cancer Treatment Breakthroughs Improve Survival, Advance Evidence-Based Choices
FORT WASHINGTON, PA--(Marketwired - October 09, 2014) - The National Comprehensive Cancer Network® (NCCN®) has published the 20th annual editions of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Colon and Rectal Cancers, two of the eight original NCCN Guidelines® published in November 1996. 

Philadelphia Plastic Surgeon Upgrades Website With Responsive Design Element
In an effort create a comprehensive online resource for people seeking information about cosmetic enhancement, Dr. Louis P. Bucky recently launched a new and improved website for his Philadelphia plastic surgery practice

New Language Regarding Addiction Aims to Reduce Stigma and Blame
CHICAGO, IL--(Marketwired - December 19, 2013) - Timberline Knolls, a leading residential treatment center for women and adolescent girls struggling with addiction, eating disorders, trauma and other co-occurring disorders, applauds the recent White House summit on drug policy reform and the recommendations to change the language used to describe addiction.

FluoroPharma Medical Announces Acceptance of Abstract for Oral Presentation at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Winter Meeting
MONTCLAIR, NJ--(Marketwired - December 19, 2013) - FluoroPharma Medical, Inc

NCCN Receives Esteemed Accreditation for CME Activities
FORT WASHINGTON, PA--(Marketwired - December 17, 2013) -  The National Comprehensive Cancer Network® (NCCN®) has been surveyed by the Accreditation Council for Continuing Medical Education (ACCME) and awarded Accreditation with Commendation for six years as a provider of continuing medical education (CME) for physicians.

New York State Society of Plastic Surgeons Names New President
Manhattan plastic surgeon Stafford R. Broumand, MD has recently been announced as President of the New York State Society of Plastic Surgeons for a term that will extend until November of 2014. On his path to presidency, Dr

FluoroPharma Medical Inc. to Present at the LD Micro Sixth Annual Conference on December 5, 2013
MONTCLAIR, NJ--(Marketwired - November 27, 2013) - FluoroPharma Medical, Inc

New York Plastic Surgeon Uses Multifaceted Approach to Pain Management
Stafford R. Broumand, MD, a board-certified plastic surgeon in New York City, strives to provide his patients a comfortable and relaxing experience without compromising the surgical results they have come to expect. In order to help manage post-operative discomfort, Dr. Broumand has begun to use an innovative analgesic called EXPAREL® as part of the recovery process

NCCN Publishes New Patient Resource for Stage 0 Breast Cancer
FORT WASHINGTON, PA--(Marketwired - November 25, 2013) - The National Comprehensive Cancer Network® (NCCN®), with the support of the NCCN Foundation®, announces the availability of NCCN Guidelines for Patients®: Stage 0 Breast Cancer -- the latest addition to the library of NCCN Guidelines for Patients® available free-of-charge at NCCN.org/patients

FluoroPharma Medical Inc. Is Elected to the Medical Imaging & Technology Alliance (MITA)
MONTCLAIR, NJ--(Marketwired - November 25, 2013) - FluoroPharma Medical, Inc. (OTCQB: FPMI), a company specializing in the development of novel diagnostic imaging products that utilize positron emission tomography (PET) technology for the detection and assessment of disease before clinical manifestation, announced today that it has been elected to MITA and will be represented by Edward L

NCCN Qualifies Northside Hospital Cancer Institute for Affiliate Research Project
FORT WASHINGTON, PA--(Marketwired - November 21, 2013) - The National Comprehensive Cancer Network® (NCCN®) Affiliate Research Project (ARP), developed by the NCCN Oncology Research Program (ORP), has qualified Northside Hospital Cancer Institute for the project

WorldCare Clinical Publishes Research Manuscript Demonstrating How a Central Image Review Can Reduce Overall Clinical Trial Costs
WorldCare Clinical (WCC), a leading CRO focused on maximizing the precision and accuracy of independent assessments in clinical trials, has in collaboration with Dr

Researchers Receive Grants From NCCN Oncology Research Program Funded Through Onyx Pharmaceuticals
FORT WASHINGTON, PA--(Marketwired - November 11, 2013) - The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) recently awarded four research grants to investigators following NCCN ORP Scientific Review Committee analysis of proposals submitted in response to the NCCN Carfilzomib and Oprozomib Request for Proposals (RFP)

Actelion announces U.S. commercial availability of opsumit (macitentan) as of November 4
Actelion Pharmaceuticals Ltd /Actelion announces U.S. commercial availability of opsumit (macitentan) as of November 4 . Processed and transmitted by Thomson Reuters ONE.The issuer is solely responsible for the content of this announcement.

New York Plastic Surgeon Employs Unique Facelift Approach for Enhanced Results
Though signs of aging in the face and neck develop naturally over time, a facelift has the capacity to restore one's appearance for a more youthful look. To combat the effects that environmental factors and heredity can have on one's skin -- in addition to the natural aging process -- Dr. Stafford R

WorldCare Clinical Collaborates With Leading Researcher to Publish an Endpoint Assessment Committee Review Article
WorldCare Clinical (WCC), a leading CRO focused on maximizing the precision and accuracy of independent assessments in clinical trials, today announced a new peer-reviewed article entitled, "Subjective Endpoints in Clinical Trials: the Case for Blinded Independent Review." The article, which was written in collaboration with Drs

MBio Diagnostics, Inc. Announces the Creation of a Scientific Advisory Board
MBio Diagnostics, Inc. announced the formation of a Scientific Advisory Board (SAB) composed of medical professionals with deep expertise in global health issues. The SAB will help advance MBio Diagnostics' mission to increase access to quality healthcare by delivering innovative and low cost point-of-care (POC) diagnostics

Philadelphia Plastic Surgeon Offers 2 Unique Breast Augmentation Educational Tools
Dr. Louis Bucky, a board-certified Philadelphia plastic surgeon, performs over 150 breast augmentations a year and has worked with patients from 18-73 years old. A recognized leader in innovative techniques and technology for the procedure, Dr. Bucky has recently released a comprehensive breast augmentation guide for prospective patients.

Further positive Opsumit (macitentan) data in pulmonary arterial hypertension presented at CHEST 2013
Actelion Pharmaceuticals Ltd /Further positive Opsumit (macitentan) data in pulmonary arterial hypertension presented at CHEST 2013 . Processed and transmitted by Thomson Reuters ONE.The issuer is solely responsible for the content of this announcement.

ProScan Imaging Group Acquires 100 Percent Ownership of WorldCare Clinical LLC
ProScan Imaging, one of the world's most experienced international radiology services groups, has increased its majority ownership of WorldCare Clinical (WCC) LLC to 100 percent, positioning the organization for growth and increased synergies in technology, service offerings, expertise, and accredited educational programs to benefit their biopharmaceutical and device manufacturer customers.

WorldCare Clinical Appoints Melissa Gebhardt to Lead Business Development and Marketing Strategy
WorldCare Clinical, LLC (WCC), a leading imaging CRO focused on maximizing the precision and accuracy of independent assessments in clinical trials, today announced that Melissa Gebhardt has been appointed vice president of business development and marketing.

New York City Plastic Surgeon Reveals All in 3-Part Arm Lift Blog Series
"Popular shirts and tops these days are being designed to show a lot more of the arm and shoulder, which consequently leads to an awareness, or in some cases, an insecurity about the appearance of one's arms," states NYC plastic surgeon Stafford R. Broumand, MD in recent blog post

KCI Acquires New Skin Grafting Technology
Kinetic Concepts, Inc. has announced that it has completed its acquisition of MoMelan Technologies, Inc., a privately held medical technology company developing innovative skin grafting solutions. Terms of the transaction were not disclosed.

MPEG LA’s Librassay® Removes Patent Barriers to Diagnostics for Personalized Medicine
MPEG LA announced that Librassay®, a landmark collaboration with the National Institutes of Health (NIH) and other leading healthcare innovators (listed below), is now providing one-stop worldwide access to diagnostic discoveries for personalized medicine.

First Clinic in India to offer Coolsculpting to Reduce Fat Bulges
Life Slimming & Cosmetic Clinic (www.lifescc.com) is the first cosmetic clinic to add CoolSculpting by Zeltiq, USA to it's list of fat reduction, body contouring procedures in the country. With years of body contouring experience, Mrs

SuppreMol's SM101 shows a sustained clinical activity and a favorable safety profile in Primary Immune Thrombocytopenia (ITP) patients
SuppreMol GmbH /SuppreMol's SM101 shows a sustained clinical activity and a favorable safety profile in Primary Immune Thrombocytopenia (ITP) patients . Processed and transmitted by Thomson Reuters ONE.The issuer is solely responsible for the content of this announcement.

WorldCare Clinical Publishes Guidance on Defining the Process for Independent Endpoint Review Services in Clinical Trials
WorldCare Clinical (WCC), a leading CRO focused on maximizing the precision and accuracy of independent assessments in clinical trials, has in collaboration with Dr

Prize4Life Announces the Launch of PRO-ACT: The Largest ALS Clinical Trials Database Ever Created
Prize4Life, a nonprofit organization whose mission is to accelerate the discovery of treatments and a cure for ALS (Amyotrophic Lateral Sclerosis, also known as Lou Gehrig's disease), announced today the launch of the PRO-ACT (Pooled Resource Open-Access ALS Clinical Trials) database, the largest ALS clinical trial database ever created.

Stem Cell Media Interview With Dr. Adrian Harel: Fighting to End ALS, Once and for All
Sai Rosen of www.InvestorStemCell.com (Stem Cell Media, LLC) recently sat down with Dr. Adrian Harel, Chief Executive Officer for Brainstorm Cell Therapeutics Inc. (OTCQB: BCLI). Brainstorm Cell Therapeutics Inc

FluoroPharma Medical, Inc. Announces $1.5M Equity Financing
FluoroPharma Medical, Inc

WorldCare Clinical Expands Globally With New Offices Across Europe, S. America and Asia Pacific
WorldCare Clinical, LLC (WCC), a leading imaging CRO focused on maximizing the precision and accuracy of independent assessments in clinical trials, today announced new locations in Brazil, Dubai, Poland, Spain, and Singapore.

Prize4Life Announces $50,000 ALS Prediction Prize Winners
Prize4Life, a nonprofit organization whose mission is to accelerate the discovery of treatments and a cure for ALS (Amyotrophic Lateral Sclerosis, also known as Lou Gehrig's disease), announced today three winners of its $50,000 DREAM-Phil Bowen ALS Prediction Prize4Life Challenge (or ALS Prediction Prize), which was run in collaboration with InnoCentive, Inc

Dr. Paul Griner's 'Patient Stories' Emphasizes Value of Listening in Medicine
In his new book, "The Power of Patient Stories: Learning Moments in Medicine," Dr. Paul Griner, (http://DrPaulGriner.com), uses real-life stories culled from his 59 years as a physician to demonstrate just how crucial the doctor-patient relationship is in diagnosis and treatment.

Insulet Appoints John A. Fallon to Board of Directors
Insulet Corporation (NASDAQ: PODD), the leader in tubing-free insulin pump technology with its OmniPod® Insulin Management System, today announced the appointment of John A. Fallon, M.D., F.A.C.P. to the Company's board of directors. A leading health management expert, Dr

Zephyr Technology Announces Collaboration With Massachusetts General Hospital
Zephyr Technology, a world leader in remote physiologic monitoring, announces a collaboration program with Massachusetts General Hospital for ZephyrLIFE™ Monitoring System. Massachusetts General earned the top spot in US News and World Report's annual "Best Hospitals" for 2012

Kam Habibi Applauds Efforts to Use Plastic Surgery in Helping Veterans
While many American veterans return home with a variety of health problem, innovative professionals in the medical community have been working steadily to offer an array of reconstructive options for soldiers

Given Imaging Acquires Assets of SmartPill Corporation
Given Imaging Ltd. (NASDAQ: GIVN), a world leader in specialty GI products and pioneer of capsule endoscopy, today announced that it has acquired from The SmartPill Corporation, a U.S. based-company, the assets related to the SmartPill® GI Monitoring System for $6 million

WorldCare Clinical Introduces New Independent Review Services by Subspecialty-Trained Clinicians for Trials With Subjective Endpoints
WorldCare Clinical, LLC (WCC), a leading CRO focused on maximizing the precision and accuracy of independent assessments in clinical trials, today announced its new Endpoint Assessment Committee (EAC) services for blinded independent central review (BICR) of clinical trial data

Prana's PBT2 Clinical Trials Cited as Most Advanced in Addressing Neurodegeneration From the Metal Equilibrium Perspective
Prana Biotechnology (NASDAQ: PRAN) (ASX: PBT) today reported that it had been cited in an interview in The Life Sciences Report with George Zavoico, Ph.D., senior equity analyst and managing director with MLV & Co., as the only drug company to address in clinical trials the control of transition metal levels in neuronal synapses, a key event in age-related dysfunction of the brain

Xcovery Holdings Raises $6M in Series B Financing; Xcovery Vision Set to Begin Phase I/II Macular Degeneration Trial With Its Oral Drug Candidate
Xcovery Holdings, the parent company of Xcovery Vision, a privately held biopharmaceutical company focused on creating the next generation of eye therapeutics, today announced that it will begin its Phase I/II clinical trial of its oral angiogenesis inhibitor, X-82, for the treatment of neovascular "wet" age-related macular degeneration (AMD).

FluoroPharma Raises Revenue Forecast Citing Tremendous Progress in Pipeline
FluoroPharma Medical, Inc. (OTCBB: FPMI), a company specializing in the development of novel diagnostic imaging products that utilize positron emission tomography (PET) technology for the detection and assessment of disease before clinical manifestation, today announced a significant increase in revenue forecast.

FluoroPharma Diagnostic Imaging Products Included at Two Major Scientific Forums
FluoroPharma Medical, Inc. (OTCBB: FPMI), a company specializing in the development of novel diagnostic imaging products that utilize positron emission tomography (PET) technology for the detection and assessment of disease before clinical manifestation, today confirmed that FluoroPharma diagnostic products were included in presentations at two significant Scientific forums.

Smaller brain size may signal Alzheimer's
People with smaller regions of the brain's cortex may be more likely to develop symptoms consistent with very early Alzheimer's disease, a new study has suggested.

Neuron transplants may repair diseased brain circuitry in mammals
Carefully selected young, healthy neurons can functionally integrate into diseased brain circuitry in mammals, a new study has found.

Novel drug slows progression of Lou Gehrig's disease, cuts mortality
A novel drug dexpramipexole may help slow symptom progression in the neurodegenerative disease amyotrophic lateral sclerosis (ALS), a new study has suggested.

Gene behind increased risk of deadly skin cancer identified
A novel gene mutation that appears to increase the risk of both inherited and sporadic cases of malignant melanoma, the most deadly form of skin cancer, has been identified in a major international study.

New 'Fantastic Voyage' probe detects dangerous blood clots inside arteries
Like in the movie 'Fantastic Voyage' where a miniature submarine is send into a VIP's bloodstream to destroy a life-threatening clot, a scientist has developed a new probe that can pass through arteries to spot the most dangerous clots and deposits.

Geographical variation plays role in chronic digestive conditions
Geographic variation does play a role in determining occurrence of chronic digestive diseases, US researchers say.he new research points to a potential role for UV light exposure and vitamin D levels in chronic digestive conditions, Crohn's disease, which is a serious inflammatory condition in the small intestine and ulcerative colitis (UC), which similarly affects the colon.

Novel technique uses RNA interference to block harmful inflammations
Scientists have found a way to block the damaging inflammation that contributes to many disease conditions in an animal model.

Sami Bittar, MD, Adds CoolSculpting by ZELTIQ(TM) to Patient Services; Trim Fat in Time for the Holidays With Revolutionary, Noninvasive Technique
Seen on The Dr. Oz show, the CoolSculpting procedure is completely noninvasive, using no needles and no incisions, to selectively reduce fat bulges. The procedure uses a non-invasive applicator, applied to the skin surface, to deliver a controlled cooling to target areas. After exposure to the cooling, fat cells begin to be gradually eliminated, using the body's normal metabolic processes

The MIT Leaders for Global Operations Program Welcomes Three New Industry Partners
The MIT Leaders for Global Operations (MIT LGO) program has gotten a major boost to its roster of partner companies with the addition of three new firms -- Beth Israel Deaconess Medical Center (BIDMC), NIKE, Inc., and Verizon Wireless -- which will benefit from intensive hands-on research by MIT LGO students.

Adele's voice surgery a 'success'
Adele underwent a successful vocal chord surgery on Monday but her events for the year remain cancelled.

Comment on this story

Share